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Abstract:	 Organophosphates	such	as	methamidophos,	usually	used	in	the	agricultural	field,	have	harmful	effects	on	
humans. Exposures to insecticides has been associated with many disorders, including damage to the central and pe-
ripheral nervous system. Chronic exposure to organophosphates may lead to persistent neurological and neurobehav-
ioral	effects.	This	study	was	conducted	to	determine	the	effect	of	methamidophos	on	[3H]-dopamine (DA) and gamma 
aminobutyric	acid	(GABA)	release	from	different	brain	regions	after	chronic	exposure	to	it	for	3,	6	or	9	months.	After	
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Introduction
Insecticides are essential to the human population in 
terms	of	food	security	and	disease	prevention.	There	has	
been	an	increase	in	the	use	of	insecticides,	but	the	pests	






the cholinergic neurotransmission in the peripheral and cen-
tral nervous system1,2.	The	spectrum	of	effects	caused	by	
excess	ACh	depends	upon	the	distribution	of	the	insecticide	
in the body and the receptor type with which ACh interacts3.
On the other hand, neurotoxic and schizophrenic re-
actions, depression, and damage to memory with thought 
difficulties	have	been	observed	in	groups	of	workers	ex-
posed	to	different	insecticides4.	That	damage	can	persist	for	
some months with neuropathologic injuries and cognosci-
tive	and	neuromuscular	function	damage	with	symptoms	of	
ataxia,	convulsions,	parestesia	and	defects	in	speech,	lack	
of	memory,	insomnia	and	mental	disorder5. Exposure to or-
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and biochemical alterations in humans, such as anxiety, 
depression,	impairment	of	concentration	and	learning,	fa-
tigue,	postural	instability	and	rigidity	of	face	muscles,	bra-
dykynesia	and	transient	parkinsonism6. Exposure to phos-
phorated	insecticides	for	a	long	time	results	in	convulsions,	
respiratory damage and cardiac arrhythmia that can lead to 
cerebral anoxia7.	Comparative	studies	have	been	performed	
on	the	action	of	the	receptor	for	gamma	aminobutyric	acid	
(GABA), N-methyl-D-aspartate (NMDA), and dopamine 
(DA)	release.	With	kainic	acid	administration	by	perfusion	
and	 microdialysis,	 there	 were	 toxic	 signs	 of	 convulsions	
with greater DA, GABA and aspartate release at the stria-















The	 dose	 of	 insecticide	 to	 which	 the	 experimental	













brain regions (cerebral cortex, striatum, and hippocampus) 
were	dissected	to	perform	the	GABA	and	DA	release	ex-
periments. Tissue slices were immediately washed with a 
0.32	M	sucrose	solution	at	temperatures	ranging	from	0	to	
4	°C.
The experimental methods applied to laboratory ani-






Methamidophos (Tamaron 600®)	 formulated	 as	 a	
soluble	liquid	base	of	methamidophos	(O,S-dimethyl	phos-
phoramidothioate)	for	agricultural	use	was	purchased	from	
Bayer Chemical Corporation in Mexico.
Dihydroxyphenylethylamine,	 3,4-[7-3H(N)]-, or tri-
tiated	 [3H]-dopamine	 ([3H]-DA)	 (31	 Ci/mmol)	 and	 γ	
-[2,3-3H(N)]-aminobutyric	 acid	 (-[3H]-GABA)	 (36.8	 Ci/
mmol)	were	purchased	from	New	England	Nuclear,	Wilm-
ington,	DE,	USA.	All	other	reagents	were	from	Sigma-Al-
drich (St. Louis, MO, USA).
[3H]-DA and [3H]-GABA
Release experiments were conducted in accordance 
with	the	following	protocol:	to	measure	the	[3H]-DA baseline 
flow,	a	Krebs-bicarbonate	medium	was	made	with	115	mM	
NaCl,	 3	mM	 KCl,	 1.2	mM	 Mg2SO4, 1.2  mM NaH2PO4, 
25 mM NaHCO3, 1.5 mM CaCl2, 10 mM glucose, 0.1 mM 
ascorbic	acid	and	25	μM	Iproniazide	and	adjusted	to	pH	7.4	
with a CO2-O2	mixture	(5–95%).	For	[ 3H]-GABA, release 
experiments	were	carried	out	as	[3H]-DA release using only 
the incubation medium containing 1 mM aminooxyacetic 


























Collateral effects of methamidophos treatment
Treatment	 of	 the	 animals	 with	 methamidophos	 pro-
duced	a	significant	body	weight	reduction	at	the	end	of	the	
6-month	period,	and	a	loss	of	25%	was	observed	within	6	
and	9	months	of	treatment	(data	not	shown).	All	animals	Noriega-Ortega, Armienta-Aldana, Cervantes-Pompa et al. 165
showed tonic convulsive seizures characterized by a gen-
eralized	body	tremor;	the	latency	time	was	observed	to	be	
between	7	and	15	min	after	receipt	of	the	methamidophos	
treatment. The convulsive duration was approximately 
20 min, and some aggressive behavior was also observed in 
some	animals	after	5–6	months	of	treatment.	During	acute	
poisoning, it was also observed that the mice had white 
eyes,	spiky	hair	and	sometimes	nosebleed.
Cortical and hippocampal [3H]-GABA release










On	the	other	hand,	stimulated	[3H]-GABA release in 
hippocampal slices was also decreased by methamidophos 
exposure	 during	 the	 initial	 6	 months	 of	 this	 study	 (Fig.	
2a–b).	However,	at	the	end	of	9	months	of	methamidophos	
treatment,	changes	in	stimulated	[3H]-GABA release were 
observed	at	the	hippocampal	region	(Fig.	2c).	No	differenc-








[3H]-DA release at the striatum compared with the control 
(Fig.	3b).	Basal	[3H]-DA	release	was	not	modified	in	any	of	
the groups during the study period.
Discussion
Organophosphates	 represent	 a	 group	 of	 compounds	








separated into autonomic nervous system, neuromuscular 
junction, and central nervous system (CNS) categories3.
Fig. 1.	[ 3H]-GABA	release	from	cerebral	cortex	slices	of	mice	exposed	to	methamidophos.	Statistics	are	presented	as	the	
mean	±	SEM	of	six–seven	experiments	(n=1	per	experiment)	with	determinations	duplicated.	Statistically	different	











the control group (   and  :	p<0.001	and	p<0.05,	respectively).
Fig. 3.	[ 3H]-DA	release	from	striatal	slices	of	mice	exposed	to	methamidophos.	Statistics	are	presented	as	the	mean	±	
SEM	of	six–seven	experiments	(n=1	per	experiment)	with	determinations	duplicated.Noriega-Ortega, Armienta-Aldana, Cervantes-Pompa et al. 167
cesses, the enzyme(s) that metabolizes the neurotransmit-
ter, the receptors and postsynaptic events associated with 
receptor	activation.	Some	neurotoxicants	can	interfere	with	
neurotransmission	 indirectly	 by	 interacting,	 for	 example,	
with energy metabolism, sodium channels or ATPases. Fur-




was associated with convulsive seizures shown by the mice 
after	 methamidophos	 administration,	 indicating	 reduced	
neurotransmission	as	a	result	of	neuronal	damage	in	the	re-
gion	studied.	A	possible	decrease	in	release	of	GABA	and	
concomitant increase in seizure susceptibility have been 
demostrated	by	blocking	the	GABA-gated	chloride	chan-
nel12.	A	similar	work13 showed that treatment with aldrin, 
an organochlorine insecticide, made rats more susceptible 
to	sound-induced	seizures,	suggesting	the	involvement	of	
both	noradrenergic	and	alteration	excitability	of	the	CNS	
with the observed increments in seizure susceptibility. Fur-
thermore, organophosphoruses owe their acute toxicity to 
inhibition	of	AChE	and	accumulation	of	ACh	at	cholinergic	
receptors. Chronic exposure to these compounds results in 
the	development	of	tolerance	for	their	toxicity,	which	was	
associated	with	a	decrease	in	the	density	of	muscarinic	and	
nicotinic receptors in both the central and peripheral ner-
vous systems14.
These	works	may	suggest	that	developmental	exposure	
to insecticides elicits long-lasting alterations in cell-signal-
ing cascades that are shared by multiple neurotransmitters 
and	hormonal	inputs;	the	resultant	abnormalities	of	synaptic	
communication	are	thus	likely	to	occur	in	widespread	neu-




sive ACh accumulation at synapses, where only small quan-
tities	of	ACh	are	needed	for	transmission.	Agent-induced	
ACh	accumulation	generates	side	effects	that	involve	action	
on other CNS neurotransmitter systems (e.g., norepineph-
rine,	dopamine,	and	γ-amino	butyric	acid).	The	interplay	of	
various neurotransmitters within the nervous system prob-
ably	results	in	these	varied	side	effects15, although nerve 
agents	may	exert	direct	effects	on	these	same	noncholiner-
gic systems16.
Developmental neurotoxicity is concerned with ad-
verse	health	effects	of	exogenous	agents	acting	on	neurode-
velopment. Because human brain development is a delicate 
process	involving	many	cellular	events,	the	developing	fetus	
is rather susceptible to compounds that can alter the struc-
ture	and	function	of	the	brain.	Today,	there	is	clear	evidence	
that early exposure to many neurotoxicants can severely 
damage the developing nervous system. Although, in recent 






rotoxicity experiments are nonquantal in nature, an adverse 
health	effect	will	be	defined	as	a	response	that	occurs	with	
very small probability in unexposed animals1.
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